Successful treatment of alopecia areata with efalizumab

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 12, 2008, Pages 1519-1520

  Kolde, G ^a   Meffert, H ^a   Rowe, E ^a  

^a Dermatologic Center Berlin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; DITHRANOL; EFALIZUMAB; MINOXIDIL; PREDNISOLONE; TRIAMCINOLONE ACETONIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ALOPECIA AREATA; CASE REPORT; CLINICAL FEATURE; DRUG COST; DRUG EFFECT; DRUG PULSE THERAPY; DRUG TOLERABILITY; FEMALE; HAIR GROWTH; HAIR LOSS; HUMAN; INFORMED CONSENT; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OBESITY; PRIORITY JOURNAL; PSORIASIS VULGARIS;

ADULT; ALOPECIA AREATA; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TREATMENT OUTCOME;

EID: 56549118393     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02665.x     Document Type: Letter

References (6)

1. Jullien D, Prinz JC, Langley RG et al. T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action. Dermatology 2004 208 : 297 306.
2. Gilhar A, Kalish RS. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006 5 : 64 69.
3. McMichael AJ. The new biologics in psoriasis: possible treatments for alopecia areata. J Invest Dermatol Symp Proc 2003 8 : 217 218.
4. MacDonald Hull SP, Wood ML, Hutchinson PE et al. Guidelines for the management of alopecia areata. Br J Dermatol 2003 149 : 692 699.
5. Carey W et al. Taper regimens in the management of patient discontinuing efalizumab therapy. Poster presented at the International Psoriasis Symposium. Toronto, Canada. 10 13 June 2004.
6. Kaelin U, Hassan AS, Braathen LR, Yawalkar N. Treatment of alopecia areata partim universalis with efalizumab. J Am Acad Dermatol 2006 55 : 529 532.